Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials

被引：0
|
作者：
Ball, Somedeb [1 ]
Behera, Tapas Ranjan [2 ]
Adhikari, Nimesh [1 ]
Anwer, Faiz [3 ]
Chakraborty, Rajshekhar [3 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA
[3] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
multiple myeloma; carfilzomib; renal adverse events; meta-analysis; MM;
D O I：
10.1016/j.clml.2019.07.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-262
引用
收藏
页码：S332 / S332
页数：1
相关论文
共 50 条
  • [1] Risk of Renal Toxicities with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ball, Somedeb
    Anwer, Faiz
    Behera, Tapas Ranjan
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E114 - E115
  • [2] Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Wongsaengsak, Sariya
    Khandelwal, Nuvneet
    Chakraborty, Rajshekhar
    BLOOD, 2019, 134
  • [3] Infection risk with carfilzomib in multiple myeloma: a systematic review and meta-analysis of randomised controlled trials
    Wongsaengsak, Sariya
    Kopel, Jonathan
    Behera, Tapas R.
    Chakraborty, Rajshekhar
    Ball, Somedeb
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : E95 - E97
  • [4] A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of Hematological Toxicities in Patients with Multiple Myeloma Treated with Daratumumab
    Win, Myint
    Thein, Kyaw
    Phyu, Ei
    Han, Myat
    D'Cunha, Nicholas
    Tijani, Lukman
    Currie, Mark
    Quick, Donald
    Pendergrast, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S243
  • [5] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Somedeb Ball
    Tapas Ranjan Behera
    Faiz Anwer
    Rajshekhar Chakraborty
    Annals of Hematology, 2020, 99 : 1265 - 1271
  • [6] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Anwer, Faiz
    Chakraborty, Rajshekhar
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1265 - 1271
  • [7] Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials
    Rahman, M. Rubayat
    Ball, Somedeb
    Paz, Pablo
    Elmassry, Mohamed
    Vutthikraivit, Wasawat
    Bandyopadhyay, Dhrubajyoti
    Lavie, Carl J.
    Fonarow, Gregg C.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 610 - 612
  • [8] RISK OF HEART FAILURE WITH CARFILZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Paz, Pablo
    Vutthikraivit, Wasawat
    Mantilla, Barbara
    El Nawaa, Saif
    Wongsanegsak, Sally
    Elmassry, Mohamed
    Rahman, M. Rubayat
    Whisenant, Ty
    Ball, Somedeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 986 - 986
  • [9] Daratumumab-Related Pulmonary Toxicities in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Win, Myint
    Thein, Kyaw
    Phyu, Ei
    Han, Myat
    D'Cunha, Paul
    Nelson, Joseph, III
    Quick, Donald
    Sklar, Allan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S242
  • [10] Systematic review and meta-analysis of randomized controlled trials of erythropoietin in multiple myeloma.
    Soares, HP
    Kumar, A
    Silvestri, F
    Djulbegovic, B
    BLOOD, 2004, 104 (11) : 70A - 70A
12345